• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SRPK1和Clk/Sty蛋白激酶对富含丝氨酸/精氨酸的剪接因子表现出不同的底物特异性。

SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors.

作者信息

Colwill K, Feng L L, Yeakley J M, Gish G D, Cáceres J F, Pawson T, Fu X D

机构信息

Programme in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.

出版信息

J Biol Chem. 1996 Oct 4;271(40):24569-75. doi: 10.1074/jbc.271.40.24569.

DOI:10.1074/jbc.271.40.24569
PMID:8798720
Abstract

Serine/arginine-rich (SR) proteins are essential for pre-mRNA splicing, and modify the choice of splice site during alternative splicing in a process apparently regulated by protein phosphorylation. Two protein kinases have been cloned that can phosphorylate SR proteins in vitro: SRPK1 and Clk/Sty. Here, we show that these two kinases phosphorylate the same SR proteins in vitro, but that SRPK1 has the higher specific activity toward ASF/SF2. SRPK1, like Clk/Sty, phosphorylates ASF/SF2 in vitro on sites that are also phosphorylated in vivo. Tryptic peptide mapping of ASF/SF2 revealed that three of the phosphopeptides from full-length ASF/SF2 phosphorylated in vitro contain consecutive phosphoserine-arginine residues or phosphoserine-proline residues. In vitro, the Clk/Sty kinase phosphorylated Ser-Arg, Ser-Lys, or Ser-Pro sites, whereas SRPK1 had a strong preference for Ser-Arg sites. These results suggest that SRPK1 and Clk/Sty may play different roles in regulating SR splicing factors, and suggest that Clk/Sty has a broader substrate specificity than SRPK1.

摘要

富含丝氨酸/精氨酸(SR)的蛋白质对于前体mRNA剪接至关重要,并在一个明显受蛋白质磷酸化调控的过程中,在可变剪接期间改变剪接位点的选择。已经克隆出两种能在体外使SR蛋白磷酸化的蛋白激酶:SRPK1和Clk/Sty。在此,我们表明这两种激酶在体外能使相同的SR蛋白磷酸化,但SRPK1对ASF/SF2具有更高的比活性。与Clk/Sty一样,SRPK1在体外使ASF/SF2磷酸化的位点也是其在体内被磷酸化的位点。对ASF/SF2进行胰蛋白酶肽图谱分析显示,体外磷酸化的全长ASF/SF2的三个磷酸肽含有连续的磷酸丝氨酸-精氨酸残基或磷酸丝氨酸-脯氨酸残基。在体外,Clk/Sty激酶使丝氨酸-精氨酸、丝氨酸-赖氨酸或丝氨酸-脯氨酸位点磷酸化,而SRPK1强烈偏好丝氨酸-精氨酸位点。这些结果表明,SRPK1和Clk/Sty在调节SR剪接因子方面可能发挥不同作用,并且表明Clk/Sty比SRPK1具有更广泛的底物特异性。

相似文献

1
SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors.SRPK1和Clk/Sty蛋白激酶对富含丝氨酸/精氨酸的剪接因子表现出不同的底物特异性。
J Biol Chem. 1996 Oct 4;271(40):24569-75. doi: 10.1074/jbc.271.40.24569.
2
The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.Clk/Sty蛋白激酶使SR剪接因子磷酸化并调节其在细胞核内的分布。
EMBO J. 1996 Jan 15;15(2):265-75.
3
Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2.SRPK与Clk/Sty激酶在剪接因子ASF/SF2磷酸化过程中的相互作用受ASF/SF2中一个对接基序的调控。
Mol Cell. 2005 Oct 7;20(1):77-89. doi: 10.1016/j.molcel.2005.08.025.
4
Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.Akt2对类Cdc2激酶(Clk/Sty)的调控、丝氨酸/精氨酸丰富(SR)蛋白的磷酸化以及胰岛素诱导的蛋白激酶CβII信使核糖核酸的可变剪接
Endocrinology. 2009 May;150(5):2087-97. doi: 10.1210/en.2008-0818. Epub 2008 Dec 30.
5
Mass spectrometric and kinetic analysis of ASF/SF2 phosphorylation by SRPK1 and Clk/Sty.SRPK1和Clk/Sty对ASF/SF2磷酸化的质谱分析和动力学分析
J Biol Chem. 2005 Dec 16;280(50):41761-8. doi: 10.1074/jbc.M504156200. Epub 2005 Oct 13.
6
Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1.蛋白磷酸酶 1 使 SR 蛋白 ASF/SF2 去磷酸化的机制。
J Mol Biol. 2010 Oct 29;403(3):386-404. doi: 10.1016/j.jmb.2010.08.024. Epub 2010 Sep 6.
7
Regiospecific phosphorylation control of the SR protein ASF/SF2 by SRPK1.SRPK1对SR蛋白ASF/SF2的区域特异性磷酸化调控
J Mol Biol. 2009 Jul 24;390(4):618-34. doi: 10.1016/j.jmb.2009.05.060. Epub 2009 May 27.
8
Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.激酶结构域插入决定了CLK激酶在SR蛋白磷酸化中的不同作用。
Structure. 2009 Mar 11;17(3):352-62. doi: 10.1016/j.str.2008.12.023.
9
Identification of hot spot residues on serine-arginine protein kinase-1 by molecular dynamics simulation studies.通过分子动力学模拟研究鉴定丝氨酸-精氨酸蛋白激酶-1 的热点残基。
J Biomol Struct Dyn. 2021 Mar;39(5):1579-1587. doi: 10.1080/07391102.2020.1734487. Epub 2020 Mar 4.
10
The protein kinase Clk/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing.蛋白激酶Clk/Sty直接调节SR蛋白活性:过度磷酸化和低磷酸化均会抑制剪接。
Mol Cell Biol. 1999 Oct;19(10):6991-7000. doi: 10.1128/MCB.19.10.6991.

引用本文的文献

1
Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC.药理学CLK抑制作用会破坏SR蛋白功能并阻断RNA剪接,从而抑制三阴性乳腺癌细胞的生长和迁移。
Breast Cancer Res. 2025 Jul 29;27(1):140. doi: 10.1186/s13058-025-02091-w.
2
Signal transduction pathways controlling gene activity and beta cell state transitions.控制基因活性和β细胞状态转变的信号转导通路。
iScience. 2025 Feb 17;28(3):112015. doi: 10.1016/j.isci.2025.112015. eCollection 2025 Mar 21.
3
The U1-70K and SRSF1 interaction is modulated by phosphorylation during the early stages of spliceosome assembly.
U1-70K 和 SRSF1 的相互作用在剪接体组装的早期阶段通过磷酸化进行调节。
Protein Sci. 2024 Aug;33(8):e5117. doi: 10.1002/pro.5117.
4
SR proteins in cancer: function, regulation, and small inhibitor.癌症中的 SR 蛋白:功能、调控和小分子抑制剂。
Cell Mol Biol Lett. 2024 May 22;29(1):78. doi: 10.1186/s11658-024-00594-6.
5
Functions of SRPK, CLK and DYRK kinases in stem cells, development, and human developmental disorders.SRPK、CLK 和 DYRK 激酶在干细胞、发育和人类发育障碍中的功能。
FEBS Lett. 2023 Oct;597(19):2375-2415. doi: 10.1002/1873-3468.14723. Epub 2023 Sep 4.
6
A global analysis on the differential regulation of RNA binding proteins (RBPs) by TNF-α as potential modulators of metabolic syndromes.肿瘤坏死因子-α对RNA结合蛋白(RBPs)的差异调节作为代谢综合征潜在调节因子的全球分析。
BBA Adv. 2021 Dec 29;2:100037. doi: 10.1016/j.bbadva.2021.100037. eCollection 2022.
7
Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases.Cdc2 样激酶:结构、生物学功能及疾病治疗靶点。
Signal Transduct Target Ther. 2023 Apr 7;8(1):148. doi: 10.1038/s41392-023-01409-4.
8
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia.RNA 剪接的调节增强了白血病中对 BCL2 抑制的反应。
Cancer Cell. 2023 Jan 9;41(1):164-180.e8. doi: 10.1016/j.ccell.2022.12.002. Epub 2022 Dec 22.
9
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication.宿主蛋白激酶是 SARS-CoV-2 核衣壳磷酸化和病毒复制所必需的。
Sci Signal. 2022 Oct 25;15(757):eabm0808. doi: 10.1126/scisignal.abm0808.
10
Phosphoproteomics Unravel HBV Triggered Rewiring of Host Phosphosignaling Events.磷酸化蛋白质组学揭示 HBV 触发的宿主磷酸化信号事件重排。
Int J Mol Sci. 2022 May 4;23(9):5127. doi: 10.3390/ijms23095127.